Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC

Abdijadid, 2015, Basic mechanisms of epileptogenesis in pediatric cortical dysplasia, CNS Neurosci Ther, 21, 92, 10.1111/cns.12345 Abs, 2013, TORC1-dependent epilepsy caused by acute biallelic Tsc1 deletion in adult mice, Ann Neurol, 74, 569, 10.1002/ana.23943 Anderl, 2011, Therapeutic value of prenatal rapamycin treatment in a mouse brain model of tuberous sclerosis complex, Hum Mol Genet, 20, 4597, 10.1093/hmg/ddr393 Aronica, 2014, Epilepsy related to developmental tumors and malformations of cortical development, Neurotherapeutics, 11, 251, 10.1007/s13311-013-0251-0 Au, 2007, Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States, Genet Med, 9, 88, 10.1097/GIM.0b013e31803068c7 Berg, 2010, Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009, Epilepsia, 51, 676, 10.1111/j.1528-1167.2010.02522.x Boer, 2010, Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors, Brain Pathol, 20, 704, 10.1111/j.1750-3639.2009.00341.x Bolton, 1997, Association of tuberous sclerosis of temporal lobes with autism and atypical autism, Lancet, 349, 392, 10.1016/S0140-6736(97)80012-8 Bombardieri, 2010, Early control of seizures improves long-term outcome in children with tuberous sclerosis complex, Eur J Paediatr Neurol, 14, 146, 10.1016/j.ejpn.2009.03.003 Boronat, 2014, Tuberous sclerosis complex without tubers and subependymal nodules: a phenotype-genotype study, Clin Genet, 86, 149, 10.1111/cge.12245 Cepeda, 2014, Pacemaker GABA synaptic activity may contribute to network synchronization in pediatric cortical dysplasia, Neurobiol Dis, 62, 208, 10.1016/j.nbd.2013.10.001 Choi, 2008, Tuberous sclerosis complex proteins control axon formation, Genes Dev, 22, 2485, 10.1101/gad.1685008 Chu-Shore, 2010, The natural history of epilepsy in tuberous sclerosis complex, Epilepsia, 51, 1236, 10.1111/j.1528-1167.2009.02474.x Crino, 2011, mTOR: a pathogenic signaling pathway in developmental brain malformations, Trends Mol Med, 17, 734, 10.1016/j.molmed.2011.07.008 Crino, 2013, Evolving neurobiology of tuberous sclerosis complex, Acta Neuropathol, 125, 317, 10.1007/s00401-013-1085-x Curatolo, 1991, Neuropsychiatric aspects of tuberous sclerosis, Ann N Y Acad Sci, 615, 8, 10.1111/j.1749-6632.1991.tb37743.x Curatolo, 2012, Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations, Eur J Paediatr Neurol, 16, 582, 10.1016/j.ejpn.2012.05.004 Curatolo, 2015, Neurological and neuropsychiatric aspects of tuberous sclerosis complex, Lancet Neurol, 14, 733, 10.1016/S1474-4422(15)00069-1 Cusmai, 2011, Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis, Epilepsy Behav, 22, 735, 10.1016/j.yebeh.2011.08.037 Dabora, 2001, Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs, Am J Hum Genet, 68, 64, 10.1086/316951 de Vries, 2007, The tuberous sclerosis complex proteins–a GRIPP on cognition and neurodevelopment, Trends Mol Med, 13, 319, 10.1016/j.molmed.2007.06.003 Domanska-Pakiela, 2014, EEG abnormalities preceding the epilepsy onset in tuberous sclerosis complex patients – a prospective study of 5 patients, Eur J Paediatr Neurol, 18, 458, 10.1016/j.ejpn.2013.12.006 Ehninger, 2008, Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis, Nat Med, 14, 843, 10.1038/nm1788 Gipson, 2013, Potential for treatment of severe autism in tuberous sclerosis complex, World J Clin Pediatr, 2, 16, 10.5409/wjcp.v2.i3.16 Gomez, 1982, Tuberous sclerosis, early onset of seizures, and mental subnormality: study of discordant homozygous twins, Neurology, 32, 604, 10.1212/WNL.32.6.604 Goorden, 2007, Cognitive deficits in Tsc1+/− mice in the absence of cerebral lesions and seizures, Ann Neurol, 62, 648, 10.1002/ana.21317 Goyer, 2015, Use of mTOR inhibitor everolimus in three neonates for treatment of tumors associated with tuberous sclerosis complex, Pediatr Neurol, 52, 450, 10.1016/j.pediatrneurol.2015.01.004 Humphrey, 2006, Autistic regression associated with seizure onset in an infant with tuberous sclerosis, Dev Med Child Neurol, 48, 609, 10.1017/S0012162206001277 Im, 2015, Altered structural brain networks in tuberous sclerosis complex, Cereb Cortex Iyer, 2014, Cell injury and premature neurodegeneration in focal malformations of cortical development, Brain Pathol, 24, 1, 10.1111/bpa.12060 Jansen, 2008, Cognitive impairment in tuberous sclerosis complex is a multifactorial condition, Neurology, 70, 916, 10.1212/01.wnl.0000280579.04974.c0 Jeste, 2008, Characterization of autism in young children with tuberous sclerosis complex, J Child Neurol, 23, 520, 10.1177/0883073807309788 Joinson, 2003, Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex, Psychol Med, 33, 335, 10.1017/S0033291702007092 Jozwiak, 2011, Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex, Eur J Paediatr Neurol, 15, 424, 10.1016/j.ejpn.2011.03.010 Kotulska, 2014, Epilepsy in newborns with tuberous sclerosis complex, Eur J Paediatr Neurol, 18, 714, 10.1016/j.ejpn.2014.06.009 Kwiatkowski, 2014, Molecular basis of giant cells in tuberous sclerosis complex, N Engl J Med, 371, 778, 10.1056/NEJMcibr1406613 Lebrun-Julien, 2014, Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination, J Neurosci, 34, 8432, 10.1523/JNEUROSCI.1105-14.2014 Lewis, 2013, Impaired language pathways in tuberous sclerosis complex patients with autism spectrum disorders, Cereb Cortex, 23, 1526, 10.1093/cercor/bhs135 Lozovaya, 2014, Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model, Nat Commun, 5, 4563, 10.1038/ncomms5563 Marcotte, 2012, Cytoarchitectural alterations are widespread in cerebral cortex in tuberous sclerosis complex, Acta Neuropathol, 123, 685, 10.1007/s00401-012-0950-3 McMahon, 2012, Impaired autophagy in neurons after disinhibition of mammalian target of rapamycin and its contribution to epileptogenesis, J Neurosci, 32, 15704, 10.1523/JNEUROSCI.2392-12.2012 Napolioni, 2009, Recent advances in neurobiology of tuberous sclerosis complex, Brain Dev, 31, 104, 10.1016/j.braindev.2008.09.013 Numis, 2011, Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex, Neurology, 76, 981, 10.1212/WNL.0b013e3182104347 Okanishi, 2014, Interictal high frequency oscillations correlating with seizure outcome in patients with widespread epileptic networks in tuberous sclerosis complex, Epilepsia, 55, 1602, 10.1111/epi.12761 Peters, 2012, Loss of white matter microstructural integrity is associated with adverse neurological outcome in tuberous sclerosis complex, Acad Radiol, 19, 17, 10.1016/j.acra.2011.08.016 Prabowo, 2013, Fetal brain lesions in tuberous sclerosis Complex: TORC1 activation and inflammation, Brain Pathol, 23, 45, 10.1111/j.1750-3639.2012.00616.x Reith, 2013, Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex, Neurobiol Dis, 51, 93, 10.1016/j.nbd.2012.10.014 Sancak, 2005, Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype–phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex, Eur J Hum Genet, 13, 731, 10.1038/sj.ejhg.5201402 Sato, 2012, Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex, Nat Commun, 3, 1292, 10.1038/ncomms2295 Talos, 2008, Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers, Ann Neurol, 63, 454, 10.1002/ana.21342 Talos, 2012, Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia, Ann Neurol, 71, 539, 10.1002/ana.22696 Tavazoie, 2005, Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2, Nat Neurosci, 8, 1727, 10.1038/nn1566 Tsai, 2013, Prenatal rapamycin results in early and late behavioral abnormalities in wildtype C57B1/6 mice, Behav Genet, 41, 51, 10.1007/s10519-012-9571-9 Tsai, 2012, Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice, Nature, 488, 647, 10.1038/nature11310 Tsai, 2014, Fetal brain mTOR signaling activation in tuberous sclerosis complex, Cereb Cortex, 24, 315, 10.1093/cercor/bhs310 van Eeghen, 2013, The neuroanatomical phenotype of tuberous sclerosis complex: focus on radial migration lines, Neuroradiology, 55, 1007, 10.1007/s00234-013-1184-3 Vargas, 2005, Neuroglial activation and neuroinflammation in the brain of patients with autism, Ann Neurol, 57, 67, 10.1002/ana.20315 von der Brelie, 2006, Impaired synaptic plasticity in a rat model of tuberous sclerosis, Eur J Neurosci, 23, 686, 10.1111/j.1460-9568.2006.04594.x Waltereit, 2011, Epilepsy and Tsc2 haploinsufficiency lead to autistic-like social deficit behaviors in rats, Behav Genet, 41, 364, 10.1007/s10519-010-9399-0 Wang, 2007, Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1, Ann Neurol, 61, 139, 10.1002/ana.21058 Way, 2012, The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex, Hum Mol Genet, 21, 3226, 10.1093/hmg/dds156 Weichhart, 2009, The multiple facets of mTOR in immunity, Trends Immunol, 30, 218, 10.1016/j.it.2009.02.002 White, 2001, Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers, Ann Neurol, 49, 67, 10.1002/1531-8249(200101)49:1<67::AID-ANA10>3.0.CO;2-L Wu, 2015 Yasin, 2013, mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis, Acta Neuropathol, 126, 207, 10.1007/s00401-013-1135-4 Zeng, 2007, Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex, Neurobiol Dis, 28, 184, 10.1016/j.nbd.2007.07.015 Zeng, 2008, Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex, Ann Neurol, 63, 444, 10.1002/ana.21331 Zhang, 2013, Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex, PLoS One, 8, e57445, 10.1371/journal.pone.0057445 Zhang, 2015, Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex, Neurobiol Dis, 80, 70, 10.1016/j.nbd.2015.04.016 Yeung, 1997, Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis, Am J Pathol., 151, 1477 Waltereit, 2006, Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis, J Neurochem., 96, 407, 10.1111/j.1471-4159.2005.03538.x